20 mayo 2015
A novel drug target for the treatment of rheumatoid arthritis has been identified, which focuses on the cells that are directly responsible for the cartilage damage in affected joints. Rheumatoid arthritis, an autoimmune disease that leads to stiff, deformed joints and often crippling pain, affects around 1.5 million adults in the United States. The immune system’s attack on the body’s own tissue leads to chronic, painful inflammation in the affected joints.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Q-7kCKal-YU/150520140610.htm
